ABI-013

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameABI-013
Drug Alias Namenab-ABI-139nanoparticle albumin-bound ABI-139 (Abraxis)nab-CY196nanoparticle albumin-bound ABI-139 (Celgene)ABI-013
ClassificationBiologics
Mechanisms of ActionMicrotubule stabilizer
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbraxis Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbraxis Bioscience IncCelgene Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A